89
Views
5
CrossRef citations to date
0
Altmetric
Original Research

In vitro reduction of colistin susceptibility and comparative genomics reveals multiple differences between MCR-positive and MCR-negative colistin-resistant Escherichia coli

, , , , , , , & show all
Pages 1665-1674 | Published online: 12 Jun 2019

References

  • Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557–596. doi:10.1128/CMR.00064-1628275006
  • Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168. doi:10.1016/S1473-3099(15)00424-726603172
  • Wang X, Liu Y, Qi X, et al. Molecular epidemiology of colistin-resistant Enterobacteriaceae in inpatient and avian isolates from China: high prevalence of mcr-negative Klebsiella pneumoniae. Int J Antimicrob Agents. 2017;50(4):536–541. doi:10.1016/j.ijantimicag.2017.05.00928668693
  • Cao L, Li X, Xu Y, Shen J. Prevalence and molecular characteristics of mcr-1 colistin resistance in Escherichia coli: isolates of clinical infection from a Chinese University Hospital. Infect Drug Resist. 2018;11:1597–1603. doi:10.2147/IDR.S16672630310295
  • Li Y, Lin X, Yao X, et al. Synergistic antimicrobial activity of colistin in combination with rifampin and azithromycin against Escherichia coli producing MCR-1. Antimicrob Agents Chemother. 2018;62(12):e01631–e01618. doi:10.1128/AAC.01631-18
  • Lee JY, Ko KS. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates. Diagn Microbiol Infect Dis. 2014;78(3):271–276. doi:10.1016/j.diagmicrobio.2013.11.02724412662
  • Thi Khanh Nhu N, Dw R, Do Hoang Nhu T, et al. The induction and identification of novel Colistin resistance mutations in Acinetobacter baumannii and their implications. Sci Rep. 2016;6:28291. doi:10.1038/srep2829127329501
  • Hua X, Liu L, Fang Y, et al. Colistin resistance in acinetobacter baumannii MDR-ZJ06 revealed by a multiomics approach. Front Cell Infect Micro. 2017;7:45. doi:10.3389/fcimb.2017.00045
  • Fernandez L, Alvarez-Ortega C, Wiegand I, et al. Characterization of the polymyxin B resistome of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013;57(1):110–119. doi:10.1128/AAC.01583-1223070157
  • Quesada A, Porrero MC, Tellez S, Palomo G, Garcia M, Dominguez L. Polymorphism of genes encoding PmrAB in colistin-resistant strains of Escherichia coli and Salmonella enterica isolated from poultry and swine. J Antimicrob Chemother. 2015;70(1):71–74. doi:10.1093/jac/dku32025150146
  • Arena F, Henrici De Angelis L, Cannatelli A, et al. Colistin resistance caused by inactivation of the mgrb regulator is not associated with decreased virulence of sequence type 258 KPC carbapenemase-producing klebsiella pneumoniae. Antimicrob Agents Chemother. 2016;60(4):2509–2512. doi:10.1128/AAC.02981-1526824959
  • Phan MD, Nhu NTK, Achard MES, et al. Modifications in the pmrB gene are the primary mechanism for the development of chromosomally encoded resistance to polymyxins in uropathogenic Escherichia coli. J Antimicrob Chemother. 2017;72(10):2729–2736. doi:10.1093/jac/dkx20429091192
  • Luo Q, Yu W, Zhou K, et al. Molecular epidemiology and colistin resistant mechanism of MCR-Positive and MCR-Negative clinical isolated Escherichia Coli. Front Microbiol. 2017;8:2262.29250039
  • Zhou K, Luo Q, Wang Q, et al. Silent transmission of an IS1294b-deactivated mcr-1 gene with inducible colistin resistance. Int J Antimicrob Agents. 2018;51(6):822–828. doi:10.1016/j.ijantimicag.2018.01.00429339296
  • Rosche WA, Foster PL. Determining mutation rates in bacterial populations. Methods. 2000;20(1):4–17. doi:10.1006/meth.1999.090110610800
  • Deatherage DE, Barrick JE. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol Biol. 2014;1151:165–188. doi:10.1007/978-1-4939-0554-6_1224838886
  • San Millan A, Toll-Riera M, Qi Q, MacLean RC. Interactions between horizontally acquired genes create a fitness cost in Pseudomonas aeruginosa. Nat Commun. 2015;6:6845. doi:10.1038/ncomms784525897488
  • Liu D, Liu ZS, Hu P, et al. Characterization of surface antigen protein 1 (SurA1) from Acinetobacter baumannii and its role in virulence and fitness. Vet Microbiol. 2016;186(15):126–138. doi:10.1016/j.vetmic.2016.02.01827016767
  • Bachman MA, Breen P, Deornellas V, et al. Genome-Wide Identification of Klebsiella pneumoniae Fitness Genes during Lung Infection. mBio. 2015;6(3):e00775. doi:10.1128/mBio.00775-1526060277
  • Garcia-Quintanilla M, Pulido MR, Moreno-Martinez P, et al. Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide. Antimicrob Agents Chemother. 2014;58(5):2972–2975. doi:10.1128/AAC.02642-1324566189
  • Lin MF, Lin YY, Lan CY. Contribution of EmrAB efflux pumps to colistin resistance inAcinetobacter Baumannii. J Microbiol. 2017;55(2):130–136.28120193
  • Machado D, Antunes J, Simoes A, et al. Contribution of efflux to colistin heteroresistance in a multidrug resistant Acinetobacter baumannii clinical isolate. J Med Microbiol. 2018;67(6):740–749. doi:10.1099/jmm.0.00074129717972
  • Ni W, Li Y, Guan J, et al. Effects of efflux pump inhibitors on colistin resistance in multidrug-resistant gram-negative bacteria. Antimicrob Agents Chemother. 2016;60(5):3215–3218. doi:10.1128/AAC.00248-1626953203
  • Poole K, Lau CH, Gilmour C, Hao Y, Lam JS. Polymyxin susceptibility in pseudomonas aeruginosa linked to the MexXY-OprM multidrug efflux system. Antimicrob Agents Chemother. 2015;59(12):7276–7289. doi:10.1128/AAC.01785-1526369970
  • Eguchi Y, Okada T, Minagawa S, et al. Signal transduction cascade between EvgA/EvgS and PhoP/PhoQ two-component systems of Escherichia Coli. J Bacteriol. 2004;186(10):3006–3014.15126461
  • Nishino K, Yamaguchi A. Overexpression of the response regulator evgA of the two-component signal transduction system modulates multidrug resistance conferred by multidrug resistance transporters. J Bacteriol. 2001;183(4):1455–1458. doi:10.1128/JB.183.4.1455-1458.200111157960
  • Velkov T, Deris ZZ, Huang JX, et al. Surface changes and polymyxin interactions with a resistant strain of Klebsiella Pneumoniae. Innate Immun. 2014;20(4):350–363. doi:10.1177/175342591349333723887184
  • Mu X, Wang N, Li X, et al. The effect of colistin resistance-associated mutations on the fitness of acinetobacter baumannii. Front Microbiol. 2016;7:1715. doi:10.3389/fmicb.2016.0171527847502
  • Zusman O, Altunin S, Koppel F, Dishon Benattar Y, Gedik H, Paul M. Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis. J Antimicrob Chemother. 2017;72(1):29–39. doi:10.1093/jac/dkw37727624572
  • Gregoire N, Aranzana-Climent V, Magreault S, Marchand S, Clinical pharmacokinetics CW. Pharmacodynamics of colistin. Clin Pharmacokinet. 2017;56(12):1441–1460. doi:10.1007/s40262-017-0561-128550595